ArticleMolecular biology reports2022

Immunotherapeutic role of cabazitaxel treatment in the activation of TLR3 signalling in metastatic castration-resistant prostate cancer in vitro.

Asuman Deveci Ozkan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.